abstract |
The present invention relates to a composition comprising stem cells, wherein a composition or a cell treatment agent containing stem cells of the present invention induces an initial increase of inflammatory cytokines, and the expression of iNOS and the synthesis of nitrogen monoxide in the large macrophages Which has antibiotic effect, can prevent or treat pulmonary diseases, and can provide a source technology for inflammatory diseases and can be usefully used in the pharmaceutical industry. |